Shanghai Pharma signs deal with DHL to prepare for 'rapid global expansion'

Shanghai Pharmaceuticals (601607.SS), one of China’s largest listed pharma groups, has signed a memorandum of understanding (MOU) with the contract logistics firm DHL Supply Chain, to prepare its logistics infrastructure for what the company calls ‘rapid global expansion.’

Under the MOU, the pharma company – which generated revenues of more than $18 billion last year – will partner with DHL Supply Chain to enhance quality control measures, streamline distribution processes, and strengthen compliance with local and international food and pharmaceutical regulations.

"The quality and resilience of our logistics infrastructure will determine our ability to capitalize on the huge international growth opportunity for high-grade Chinese pharmaceutical products"